Usana Health Sciences
USNA
173 hedge funds and large institutions have $1.14B invested in Usana Health Sciences in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 52 increasing their positions, 68 reducing their positions, and 43 closing their positions.
0.43% more ownership
Funds ownership: 61% → 61.43% (+0.43%)
5% less capital invested
Capital invested by funds: $1.19B → $1.14B (-$54.7M)
8% less funds holding
Funds holding: 188 → 173 (-15)
24% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 68
28% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 43
93% less call options, than puts
Call options by funds: $1.93M | Put options by funds: $29.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$76.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.9M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$17.4M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$10.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$9.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$33.3M |
| 2 |
Millennium Management
New York
|
-$9.83M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$9.61M |
| 4 |
Renaissance Technologies
New York
|
-$9.43M |
| 5 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
-$9.23M |
USNA Hedge Fund Activity: Q2 2019 in Review
173 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2019, worth a combined $1.14B — down 4.6% from $1.19B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of USNA and 31 opened new positions — a net loss of 12 holders — while 68 trimmed existing stakes and 52 added.
The largest buyer was BlackRock, adding an estimated $76.8M. The largest seller was AJO LP, exiting entirely with an estimated $33.3M sold.
- 173 institutional investors held Usana Health Sciences (USNA) as of Q2 2019, down from 188 in Q1 2019.
- Funds reported $1.14B of Usana Health Sciences stock for Q2 2019, down 4.6% quarter-over-quarter.
- 31 funds opened new Usana Health Sciences positions in Q2 2019 and 43 closed out, a net change of -12 holders.
- The largest Usana Health Sciences buyer in Q2 2019 was BlackRock, an estimated $76.8M added.
- The largest Usana Health Sciences seller in Q2 2019 was AJO LP, an estimated $33.3M sold.
Based on aggregated 13F filings for Q2 2019.